Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Vaessen

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
Transplantation|January 15, 1996
Peripheral monitoring of direct and indirect alloantigen presentation pathways in clinical heart transplant recipientsN M van Besouw, L M Vaessen, C R Daane, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1995
Soluble tumor necrosis factor-receptors are not a useful marker of acute allograft rejection: a study in patients with renal or cardiac allograftsJ F Leeuwenberg, A H Froon, L M Vaessen, et al.
Transplant Immunology|January 1, 1994
Prophylactic therapy with OKT3 does not affect donor specific reactivity of peripheral blood lymphocytes from heart transplant recipientsN H Jutte, P Heyse, C R Daane, et al.
Transplantation|April 15, 1994
Functional and molecular characterization of graft-infiltrating T lymphocytes propagated from different biopsies derived from one heart transplant patientG Datema, L M Vaessen, R C Daane, et al.
Transplantation Proceedings|February 1, 1993
T-cell receptor V gene segment usage of graft-infiltrating T-lymphocytes after heart transplantationG Datema, L M Vaessen, C R Daane, et al.
Transplantation Proceedings|February 1, 1989
RIV-9: a mouse IgG3 anti-human CD3 monoclonal antibody with strong antigen modulating and T cell eliminating propertiesL M Vaessen, J G Kreeftenberg, P Heyse, et al.
Clinical and Experimental Immunology|May 1, 1992
Acute rejection in heart transplant patients is associated with the presence of committed donor-specific cytotoxic lymphocytes in the graft but not in the bloodL M Vaessen, C C Baan, A J Ouwehand, et al.
Transplantation Proceedings|October 1, 1991
The clinical relevance of HLA matching in heart transplantation: impact on rejection and donor-directed cytotoxicity of graft infiltrating lymphocytesC C Baan, A J Ouwehand, L M Vaessen, et al.
Human Immunology|June 1, 1990
gamma delta T-cell receptor-positive T-cell clones derived from human heart transplants do not show donor-specific cytotoxicityN H Jutte, B A Vandekerckhove, L M Vaessen, et al.
Human Immunology|April 1, 1994
Characteristics of graft-infiltrating lymphocytes after human heart transplantation. HLA mismatches and the cellular immune response within the transplanted heartA J Ouwehand, C C Baan, L M Vaessen, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Transplantation|January 15, 1996
Peripheral monitoring of direct and indirect alloantigen presentation pathways in clinical heart transplant recipientsN M van Besouw, L M Vaessen, C R Daane, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1995
Soluble tumor necrosis factor-receptors are not a useful marker of acute allograft rejection: a study in patients with renal or cardiac allograftsJ F Leeuwenberg, A H Froon, L M Vaessen, et al.
Transplant Immunology|January 1, 1994
Prophylactic therapy with OKT3 does not affect donor specific reactivity of peripheral blood lymphocytes from heart transplant recipientsN H Jutte, P Heyse, C R Daane, et al.
Transplantation|April 15, 1994
Functional and molecular characterization of graft-infiltrating T lymphocytes propagated from different biopsies derived from one heart transplant patientG Datema, L M Vaessen, R C Daane, et al.
Transplantation Proceedings|February 1, 1993
T-cell receptor V gene segment usage of graft-infiltrating T-lymphocytes after heart transplantationG Datema, L M Vaessen, C R Daane, et al.
Transplantation Proceedings|February 1, 1989
RIV-9: a mouse IgG3 anti-human CD3 monoclonal antibody with strong antigen modulating and T cell eliminating propertiesL M Vaessen, J G Kreeftenberg, P Heyse, et al.
Clinical and Experimental Immunology|May 1, 1992
Acute rejection in heart transplant patients is associated with the presence of committed donor-specific cytotoxic lymphocytes in the graft but not in the bloodL M Vaessen, C C Baan, A J Ouwehand, et al.
Transplantation Proceedings|October 1, 1991
The clinical relevance of HLA matching in heart transplantation: impact on rejection and donor-directed cytotoxicity of graft infiltrating lymphocytesC C Baan, A J Ouwehand, L M Vaessen, et al.
Human Immunology|June 1, 1990
gamma delta T-cell receptor-positive T-cell clones derived from human heart transplants do not show donor-specific cytotoxicityN H Jutte, B A Vandekerckhove, L M Vaessen, et al.
Human Immunology|April 1, 1994
Characteristics of graft-infiltrating lymphocytes after human heart transplantation. HLA mismatches and the cellular immune response within the transplanted heartA J Ouwehand, C C Baan, L M Vaessen, et al.
Pageof 9